Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses
Year: 2019
Type: article
Authors: Chikara Ohyama, Takahiro Kojima, Tsunenori Kondo, Yoshio Naya, Takamitsu Inoue, Yoshihiko Tomita, Masatoshi Eto, Shinichi Hisasue, Hirotsugu Uemura, Wataru Obara, Eiji Kikuchi, Padmanee Sharma, Matthew D. Galsky, Arlene Siefker-Radtke, Gary Grossfeld, Sandra Collette, Kyna Gooden, Go Kimura
Institutions: Hirosaki University, University of Tsukuba, Tokyo Women's Medical University, Meiji University of Integrative Medicine, Kyoto Prefectural University of Medicine, Akita University, Niigata University, Kyushu University, Kumamoto University, Chiba-Nishi General Hospital, Kindai University, Iwate Medical University, Keio University, Keio University Hospital, The University of Texas MD Anderson Cancer Center, Mount Sinai Health System, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, Bristol-Myers Squibb (United States), Nippon Medical School
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2951780832